These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

166 related articles for article (PubMed ID: 23517338)

  • 1. Effects of CXCL13 inhibition on lymphoid follicles in models of autoimmune disease.
    Finch DK; Ettinger R; Karnell JL; Herbst R; Sleeman MA
    Eur J Clin Invest; 2013 May; 43(5):501-9. PubMed ID: 23517338
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The chemokine receptor CXCR5 is pivotal for ectopic mucosa-associated lymphoid tissue neogenesis in chronic Helicobacter pylori-induced inflammation.
    Winter S; Loddenkemper C; Aebischer A; Räbel K; Hoffmann K; Meyer TF; Lipp M; Höpken UE
    J Mol Med (Berl); 2010 Nov; 88(11):1169-80. PubMed ID: 20798913
    [TBL] [Abstract][Full Text] [Related]  

  • 3. CXCR5 is critically involved in progression of lupus through regulation of B cell and double-negative T cell trafficking.
    Wiener A; Schippers A; Wagner N; Tacke F; Ostendorf T; Honke N; Tenbrock K; Ohl K
    Clin Exp Immunol; 2016 Jul; 185(1):22-32. PubMed ID: 26990531
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Role of the CXCL13/CXCR5 Axis in Autoimmune Diseases.
    Pan Z; Zhu T; Liu Y; Zhang N
    Front Immunol; 2022; 13():850998. PubMed ID: 35309354
    [TBL] [Abstract][Full Text] [Related]  

  • 5. CXCR5- and CCR7-dependent lymphoid neogenesis in a murine model of chronic antigen-induced arthritis.
    Wengner AM; Höpken UE; Petrow PK; Hartmann S; Schurigt U; Bräuer R; Lipp M
    Arthritis Rheum; 2007 Oct; 56(10):3271-83. PubMed ID: 17907173
    [TBL] [Abstract][Full Text] [Related]  

  • 6. CXCR5 expressing human central memory CD4 T cells and their relevance for humoral immune responses.
    Chevalier N; Jarrossay D; Ho E; Avery DT; Ma CS; Yu D; Sallusto F; Tangye SG; Mackay CR
    J Immunol; 2011 May; 186(10):5556-68. PubMed ID: 21471443
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The CXCL13/CXCR5-chemokine axis in neuroinflammation: evidence of CXCR5+CD4 T cell recruitment to CSF.
    Harrer C; Otto F; Pilz G; Haschke-Becher E; Trinka E; Hitzl W; Wipfler P; Harrer A
    Fluids Barriers CNS; 2021 Aug; 18(1):40. PubMed ID: 34446066
    [TBL] [Abstract][Full Text] [Related]  

  • 8. CXCL13 blockade disrupts B lymphocyte organization in tertiary lymphoid structures without altering B cell receptor bias or preventing diabetes in nonobese diabetic mice.
    Henry RA; Kendall PL
    J Immunol; 2010 Aug; 185(3):1460-5. PubMed ID: 20574003
    [TBL] [Abstract][Full Text] [Related]  

  • 9. CXCL13 antibody for the treatment of autoimmune disorders.
    Klimatcheva E; Pandina T; Reilly C; Torno S; Bussler H; Scrivens M; Jonason A; Mallow C; Doherty M; Paris M; Smith ES; Zauderer M
    BMC Immunol; 2015 Feb; 16(1):6. PubMed ID: 25879435
    [TBL] [Abstract][Full Text] [Related]  

  • 10. CXCL13 production in B cells via Toll-like receptor/lymphotoxin receptor signaling is involved in lymphoid neogenesis in chronic obstructive pulmonary disease.
    Litsiou E; Semitekolou M; Galani IE; Morianos I; Tsoutsa A; Kara P; Rontogianni D; Bellenis I; Konstantinou M; Potaris K; Andreakos E; Sideras P; Zakynthinos S; Tsoumakidou M
    Am J Respir Crit Care Med; 2013 Jun; 187(11):1194-202. PubMed ID: 23525932
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Role of CXCL13 in cigarette smoke-induced lymphoid follicle formation and chronic obstructive pulmonary disease.
    Bracke KR; Verhamme FM; Seys LJ; Bantsimba-Malanda C; Cunoosamy DM; Herbst R; Hammad H; Lambrecht BN; Joos GF; Brusselle GG
    Am J Respir Crit Care Med; 2013 Aug; 188(3):343-55. PubMed ID: 23742729
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Intracerebral expression of CXCL13 and BAFF is accompanied by formation of lymphoid follicle-like structures in the meninges of mice with relapsing experimental autoimmune encephalomyelitis.
    Magliozzi R; Columba-Cabezas S; Serafini B; Aloisi F
    J Neuroimmunol; 2004 Mar; 148(1-2):11-23. PubMed ID: 14975582
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Spin90 deficiency increases CXCL13-mediated B cell migration.
    Park SH; Kim HR; Jun CD; Song WK; Park SG
    Scand J Immunol; 2014 Sep; 80(3):191-7. PubMed ID: 24965518
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Monocyte-like and mature macrophages produce CXCL13 (B cell-attracting chemokine 1) in inflammatory lesions with lymphoid neogenesis.
    Carlsen HS; Baekkevold ES; Morton HC; Haraldsen G; Brandtzaeg P
    Blood; 2004 Nov; 104(10):3021-7. PubMed ID: 15284119
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Identification of CXCL13 as a new marker for follicular dendritic cell sarcoma.
    Vermi W; Lonardi S; Bosisio D; Uguccioni M; Danelon G; Pileri S; Fletcher C; Sozzani S; Zorzi F; Arrigoni G; Doglioni C; Ponzoni M; Facchetti F
    J Pathol; 2008 Nov; 216(3):356-64. PubMed ID: 18792075
    [TBL] [Abstract][Full Text] [Related]  

  • 16. CXCL13/CXCR5 signaling enhances BCR-triggered B-cell activation by shaping cell dynamics.
    Sáez de Guinoa J; Barrio L; Mellado M; Carrasco YR
    Blood; 2011 Aug; 118(6):1560-9. PubMed ID: 21659539
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Selectively frequent expression of CXCR5 enhances resistance to apoptosis in CD8(+)CD34(+) T cells from patients with T-cell-lineage acute lymphocytic leukemia.
    Qiuping Z; Jie X; Youxin J; Qun W; Wei J; Chun L; Jin W; Yan L; Chunsong H; Mingzhen Y; Qingping G; Qun L; Kejian Z; Zhimin S; Junyan L; Jinquan T
    Oncogene; 2005 Jan; 24(4):573-84. PubMed ID: 15580304
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Chemokine-mediated control of T cell traffic in lymphoid and peripheral tissues.
    Ebert LM; Schaerli P; Moser B
    Mol Immunol; 2005 May; 42(7):799-809. PubMed ID: 15829268
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Inflammation and ectopic lymphoid structures in rheumatoid arthritis synovial tissues dissected by genomics technology: identification of the interleukin-7 signaling pathway in tissues with lymphoid neogenesis.
    Timmer TC; Baltus B; Vondenhoff M; Huizinga TW; Tak PP; Verweij CL; Mebius RE; van der Pouw Kraan TC
    Arthritis Rheum; 2007 Aug; 56(8):2492-502. PubMed ID: 17665400
    [TBL] [Abstract][Full Text] [Related]  

  • 20. CXCL13 expression in the gut promotes accumulation of IL-22-producing lymphoid tissue-inducer cells, and formation of isolated lymphoid follicles.
    Marchesi F; Martin AP; Thirunarayanan N; Devany E; Mayer L; Grisotto MG; Furtado GC; Lira SA
    Mucosal Immunol; 2009 Nov; 2(6):486-94. PubMed ID: 19741597
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.